1. HER2 / neu Overexpression in Urothelial Carcinoma and Its Association with Tumour Grading - A Cross Sectional Study from a Tertiary Care Hospital in Kerala
   Sebina Asmi A.T et al, 2021, Journal of Evidence Based Medicine and Healthcare CrossRef
2. Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study
   Yongbao Wei et al, 2023, Frontiers in Pharmacology CrossRef
3. Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
   Tai W. Wong et al, 2006, Clinical Cancer Research CrossRef
4. Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial
   Maha H.A. Hussain et al, 2007, Journal of Clinical Oncology CrossRef
5. Urologic Cancer Molecular Biology
   Pavel Onofrei et al, 2022, Cancer Bioinformatics CrossRef